SR

Stephen B. Ruddy

EI Elan Pharma International: 15 patents #1 of 111Top 1%
SW Sterling Winthrop: 7 patents #27 of 215Top 15%
NL Nano Systems L.L.C.: 5 patents #3 of 47Top 7%
SV Shire Viropharma: 5 patents #1 of 12Top 9%
FL Fournier Laboratories Ireland Limited: 4 patents #1 of 11Top 10%
Eastman Kodak: 2 patents #3,607 of 8,114Top 45%
AL Alkermes Pharma Ireland Limited: 1 patents #80 of 116Top 70%
📍 Exton, PA: #4 of 370 inventorsTop 2%
🗺 Pennsylvania: #1,202 of 74,527 inventorsTop 2%
Overall (All Time): #86,138 of 4,157,543Top 3%
38
Patents All Time

Issued Patents All Time

Showing 1–25 of 38 patents

Patent #TitleCo-InventorsDate
11534482 C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiency Mark Manning, Ryan Erik Holcomb 2022-12-27
11364288 C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiency Mark Manning, Ryan Erik Holcomb 2022-06-21
10201595 C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiency Mark Manning, Ryan Erik Holcomb 2019-02-12
10130690 C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiency Mark Manning, Ryan Erik Holcomb 2018-11-20
10105423 C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiency Mark Manning, Ryan Erik Holcomb 2018-10-23
10080788 C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiency Mark Manning, Ryan Erik Holcomb 2018-09-25
9616111 C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiency Mark Manning, Ryan Erik Holcomb 2017-04-11
8623412 Abuse-resistant pharmaceutical compositions Vaghefi Farid, Gary Liversidge, Eugene R. Cooper 2014-01-07
8309136 In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate or nanoparticulate active agent compositions Eugene R. Cooper, John Bullock, John R. Chippari, John L. Schaefer, Rakesh Patel +3 more 2012-11-13
7998507 Nanoparticulate compositions of mitogen-activated protein (MAP) kinase inhibitors H. William Bosch, Greta G. Cary, Douglas Hovey, Rajeev Jain, Laura Kline +3 more 2011-08-16
7931917 Nanoparticulate fibrate formulations Tuula Ryde, Evan Gustow, Rajeev Jain, Rakesh Patel, Michael John Wilkins 2011-04-26
7927627 Nanoparticulate fibrate formulations Tuula Ryde, Evan Gustow, Rajeev Jain, Rakesh Patel, Michael John Wilkins 2011-04-19
7695739 In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate or nanoparticulate active agent compositions Eugene R. Cooper, John Bullock, John R. Chippari, John L. Schaefer, Rakesh Patel +3 more 2010-04-13
7320802 Methods of treatment using nanoparticulate fenofibrate compositions Tuula Ryde, Evan Gustow, Rajeev Jain, Rakesh Patel, Michael John Wilkins 2008-01-22
7276249 Nanoparticulate fibrate formulations Tuula Ryde, Evan Gustow, Rajeev Jain, Rakesh Patel, Michael John Wilkins 2007-10-02
7198795 In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions Eugene R. Cooper, John Bullock, John R. Chippari, John L. Schaefer, Rakesh Patel +3 more 2007-04-03
6908626 Compositions having a combination of immediate release and controlled release characteristics Eugene R. Cooper 2005-06-21
6592903 Nanoparticulate dispersions comprising a synergistic combination of a polymeric surface stabilizer and dioctyl sodium sulfosuccinate Niels P. Ryde 2003-07-15
6432381 Methods for targeting drug delivery to the upper and/or lower gastrointestinal tract Gary Liversidge, W. Mark Eickhoff, Kathleen J. Illig, Pramod Sarpotdar 2002-08-13
6375986 Solid dose nanoparticulate compositions comprising a synergistic combination of a polymeric surface stabilizer and dioctyl sodium sulfosuccinate Niels P. Ryde 2002-04-23
6316029 Rapidly disintegrating solid oral dosage form Rajeev Jain, Kenneth Iain Cumming, Maurice Joseph Anthony Clancy, Janet Elizabeth Codd 2001-11-13
6221400 Methods of treating mammals using nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors Gary Liversidge, David A. Engers, Mary E. Roberts, Sui-Ming Wong, Shuqian Xu 2001-04-24
6068858 Methods of making nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors using cellulosic surface stabilizers Gary Liversidge, David A. Engers, Mary E. Roberts, Sui-Ming Wong, Shuqian Xu 2000-05-30
6045829 Nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors using cellulosic surface stabilizers Gary Liversidge, David A. Engers, Mary E. Roberts, Sui-Ming Wong, Shuqian Xu 2000-04-04
5718919 Nanoparticles containing the R(-)enantiomer of ibuprofen Mary E. Roberts 1998-02-17